Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (262)
  2. Journal Article (246)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (575)
  2. Gastrointestinal Oncology Service (575)
  3. Solid Tumor Oncology Division (575)
  4. Center for Pancreatic Cancer Research (215)
  5. Epidemiology and Biostatistics (122)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (156)
  2. James Harding (130)
  3. William Jarnagin (66)
  4. Marinela Capanu (65)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (20)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Annals of Oncology (53)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (182)
  2. Oxford University Press (65)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (575)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance)
    Meeting Abstract

    Dercle, L.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Luk, L.; Liu, A.; Yang, H.; Wen, Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC)
    Meeting Abstract

    El Dika, I. H.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Yaqubie, A.; Lopez, J. C.; Huang, B. H.; Tang, Y. W.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B. M.; Ren, H.; Feliz, L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of neratinib (N), pembrolizumab (P), everolimus (E), and nivolumab (V) in patients (pts) with fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Abou-Alfa, G. K.; Meyer, T.; Zhang, J.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Xu, F.; Eli, L. D.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 3, double-blind, randomized study of nivolumab and ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma
    Meeting Abstract

    Sangro, B.; Harding, J.; Johnson, M.; Palmer, D.; Edeline, J.; Abou-Alfa, G.; Cheng, A.; Decaens, T.; El-Khoueiry, A.; Finn, R.; more...
    Journal of Vascular and Interventional Radiology (2021)

    Fulltext@MSK | Save
  • Noninvasive detection of polyclonal acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations
    Journal Article

    Varghese, A. M.; Patel, J.; Janjigian, Y. Y.; Meng, F.; Selcuklu, S. D.; Iyer, G.; Houck-Loomis, B.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair-proficient metastatic colorectal cancer
    Journal Article

    Segal, N. H.; Cercek, A.; Ku, G.; Wu, A. J.; Rimner, A.; Khalil, D. N.; Reidy-Lagunes, D.; Cuaron, J.; Yang, T. J.; Weiser, M. R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • OncoTree: A cancer classification system for precision oncology
    Journal Article

    Kundra, R.; Zhang, H.; Sheridan, R.; Sirintrapun, S. J.; Wang, A.; Ochoa, A.; Wilson, M.; Gross, B.; Sun, Y.; Madupuri, R.; more...
    JCO Clinical Cancer Informatics (2021)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with selective fibroblast growth factor receptor inhibitors: Overview, prevention, and management guidelines
    Review

    Lacouture, M. E.; Sibaud, V.; Anadkat, M. J.; Kaffenberger, B.; Leventhal, J.; Guindon, K.; Abou-Alfa, G.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study
    Meeting Abstract

    Yarchoan, M.; Cope, L.; Anders, R. A.; Noonan, A.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A.; He, A. R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save